• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 65
  • 9
  • 4
  • Tagged with
  • 76
  • 76
  • 76
  • 16
  • 16
  • 16
  • 16
  • 14
  • 14
  • 10
  • 10
  • 9
  • 9
  • 9
  • 8
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

Molecular pathology of hepatocellular carcinoma

Kee, Francis., 紀思思. January 2008 (has links)
published_or_final_version / Medicine / Doctoral / Doctor of Philosophy
2

High-throughput molecular characterization of human non-small cell lung carcinoma

Chu, Ka-wan, Kevin., 朱嘉運. January 2007 (has links)
published_or_final_version / Clinical Oncology / Master / Master of Research in Medicine
3

A study of molecular and cell biology of prostate tumorigenesis in cell culture

凌明達, Ling, Ming-tat, Patrick. January 2000 (has links)
published_or_final_version / Pathology / Master / Master of Philosophy
4

Molecular regulations of deleted in liver cancer (DLC) protein family

Ko, Chi-fat., 高自發. January 2009 (has links)
published_or_final_version / Pathology / Doctoral / Doctor of Philosophy
5

The role of cyclin E1 in hepatocellular carcinoma

Chan, Yan-yan, 陳茵茵 January 2014 (has links)
Hepatocellular carcinoma (HCC) accounts for 70-85% of liver cancer, which is the sixth most common cancer in the world. Prognosis of HCC is dismal with little chance of complete recovery after diagnosis. It is of essence to discover the key molecules involved in the tumor progression. This could help earlier detection of HCC and establish targeted molecular therapies. Cyclin E1 (CCNE1) is a cyclin molecule responsible for the transition from G1 to S phase of the cell cycle and is often dysregulated in human cancers. CCNE1 is reported with overexpression in about 30-70% of HCC cases. It expresses in tumor cells as a ladder of proteins and as low molecular weight CCNE1. The study is aimed to investigate the role of CCNE1 in HCC. From the local cohort of HCC patients, 6 out of 13 patients (46.2%) of HCC tumor tissues were found with CCNE1 overexpression compared with the non-tumor tissues by western blotting. The presence of three CCNE1 isoforms in HCC was detected. The expression of total CCNE1 and each isoform varied independently among the studied HCC cell lines, with HepG2 having the highest expression and 97L the lowest. To extend our study on the regulation of CCNE1 expression, the expression of selected four genes associating with the CCNE1 expression and functions was studied by quantitative PCR (qPCR). F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase (FBXW7) and cullin 3 (CUL3), the two genes responsible for CCNE1 degradation, had increased expression in the HCC cell lines with higher CCNE1 expression. Cyclin A (CCNA2), the downstream cyclin molecule of CCNE1, also had higher expression in these cell lines. In contrast, the expression of cyclin dependent kinase 2 (CDK2), the catalytic partner of CCNE1, had the least difference among the six HCC cell lines compared to other three genes. To characterize the role of CCNE1 isoforms in HCC, CCNE1 isoform 1, 2, and 3 were overexpressed in PLC cells and such overexpression remained even after 8 passages in culture. In flow cytometric analysis, GFP signal in cell culture population was viewed to observe the transduction efficiency. The vector control showed the strongest GFP signal, followed by CCNE1 isoform 3 showing dim signal. CCNE1 isoform 1 and 2 almost showed no signal. In the functional studies, the overexpression of CCNE1 isoform 3 could increase proliferation and migration of HCC cells. In summary, CCNE1 could promote proliferation and migration of HCC cells through elevated expression of CCNE1 isoform 3. / published_or_final_version / Surgery / Master / Master of Philosophy
6

Pathology and molecular biology of malignant thyroid tumours

Lam, King-yin, Alfred., 林敬賢. January 2004 (has links)
published_or_final_version / abstract / toc / Medicine / Master / Doctor of Medicine
7

Liver-intestine cadherin (CDH17) in hepatocellular carcinoma: molecular analysis and clinicalimplications

Zhu, Rui, 朱睿 January 2009 (has links)
published_or_final_version / Surgery / Doctoral / Doctor of Philosophy
8

Estrogenic effects of isoflavonoids on human breast cancer cells

Sze, Ivan., 施綺雯. January 2006 (has links)
published_or_final_version / Medical Sciences / Master / Master of Medical Sciences
9

Functional role of AMPK-{221}1 expression in ovarian cancer progression

Li, Cuilan, 李翠兰 January 2011 (has links)
published_or_final_version / Obstetrics and Gynaecology / Doctoral / Doctor of Philosophy
10

Role of AMPK signaling in the anti-cancer effects of silibinin in esophageal squamous cell carcinoma

Li, Jin, 李晋 January 2011 (has links)
published_or_final_version / Anatomy / Master / Master of Philosophy

Page generated in 0.0569 seconds